Insider transactions

EDGAR

Vericel Corporation

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
47 transactions, 292,205 shares
Sum of shares × price per share: 13,110,723.55

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 233

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)26334.90
9,178.7

Derived: shares × price per share. Exact value 9178.70.

1,522Direct (D) No
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)26357.78
15,196.14

Derived: shares × price per share. Exact value 15196.14.

1,259Direct (D) No
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)93534.90
32,631.5

Derived: shares × price per share. Exact value 32631.50.

2,194Direct (D) No
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)93557.62
53,874.7

Derived: shares × price per share. Exact value 53874.70.

1,259Direct (D) No
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)68729.82
20,486.34

Derived: shares × price per share. Exact value 20486.34.

1,946Direct (D) No
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)68757.80
39,708.6

Derived: shares × price per share. Exact value 39708.60.

1,259Direct (D) No
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (263) — exercise price 34.90
Acquired (A)2630—935Direct (D) No
F2
  • F2 These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (935) — exercise price 34.90
Acquired (A)9350—0Direct (D) No
F2
  • F2 These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-17SIEGAL JONATHAN Officer: Principal Accounting Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (687) — exercise price 29.82
Acquired (A)6870—2,813Direct (D) No
F3
  • F3 These options, representing the right to purchase 9,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Open filing 0001140361-26-044491 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-12Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)843.63
349.04

Derived: shares × price per share. Exact value 349.04.

16,194Direct (D) Yes
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-043494 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-12Mara Joseph Anthony Jr Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)859.75
478

Derived: shares × price per share. Exact value 478.00.

16,186Direct (D) Yes
F2, F1
  • F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-043494 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-12Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (8) — exercise price 43.63
Acquired (A)80—134,992Direct (D) Yes
F3
  • F3 These options, representing the right to purchase 160,000 shares, became exercisable on January 25, 2022, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open filing 0001140361-26-043494 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-12MCLAUGHLIN KEVIN F Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,00013.05
91,350

Derived: shares × price per share. Exact value 91350.00.

25,300Direct (D) Yes— Open filing 0001140361-26-043491 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-12MCLAUGHLIN KEVIN F Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,00058.96
412,720

Derived: shares × price per share. Exact value 412720.00.

18,300Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
Open filing 0001140361-26-043491 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-12MCLAUGHLIN KEVIN F Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (7,000) — exercise price 13.05
Acquired (A)7,0000—0Direct (D) Yes
F2
  • F2 These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open filing 0001140361-26-043491 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12ZERBE ROBERT L MD Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,00013.05
26,100

Derived: shares × price per share. Exact value 26100.00.

34,995Direct (D) Yes— Open filing 0001140361-26-043488 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12ZERBE ROBERT L MD Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,00057.88
115,760

Derived: shares × price per share. Exact value 115760.00.

32,995Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
Open filing 0001140361-26-043488 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12ZERBE ROBERT L MD Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (2,000) — exercise price 13.05
Acquired (A)2,0000—0Direct (D) Yes
F2
  • F2 These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open filing 0001140361-26-043488 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)25,00043.63
1,090,750

Derived: shares × price per share. Exact value 1090750.00.

41,186Direct (D) Yes
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-043494 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12Mara Joseph Anthony Jr Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,00058.26
1,456,500

Derived: shares × price per share. Exact value 1456500.00.

16,186Direct (D) Yes
F2, F1
  • F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-043494 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (25,000) — exercise price 43.63
Acquired (A)25,0000—135,000Direct (D) Yes
F3
  • F3 These options, representing the right to purchase 160,000 shares, became exercisable on January 25, 2022, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open filing 0001140361-26-043494 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)14,06834.90
490,973.2

Derived: shares × price per share. Exact value 490973.20.

30,254Direct (D) Yes
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)14,06853.41
751,371.88

Derived: shares × price per share. Exact value 751371.88.

16,186Direct (D) Yes
F2, F1
  • F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)14,57329.82
434,566.86

Derived: shares × price per share. Exact value 434566.86.

30,759Direct (D) Yes
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)14,57353.43
778,635.39

Derived: shares × price per share. Exact value 778635.39.

16,186Direct (D) Yes
F2, F1
  • F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (14,068) — exercise price 34.90
Acquired (A)14,0680—39,269Direct (D) Yes
F3
  • F3 These options, representing the right to purchase 64,269 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted.
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (14,573) — exercise price 29.82
Acquired (A)14,5730—21,250Direct (D) Yes
F4
  • F4 These options, representing the right to purchase 46,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)10,93234.90
381,526.8

Derived: shares × price per share. Exact value 381526.80.

27,118Direct (D) Yes
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)10,93253.40
583,768.8

Derived: shares × price per share. Exact value 583768.80.

16,186Direct (D) Yes
F2, F1
  • F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)10,42729.82
310,933.14

Derived: shares × price per share. Exact value 310933.14.

26,613Direct (D) Yes
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)10,42753.73
560,242.71

Derived: shares × price per share. Exact value 560242.71.

16,186Direct (D) Yes
F2, F1
  • F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (10,932) — exercise price 34.90
Acquired (A)10,9320—53,337Direct (D) Yes
F3
  • F3 These options, representing the right to purchase 64,269 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted.
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Mara Joseph Anthony Jr Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (10,427) — exercise price 29.82
Acquired (A)10,4270—35,823Direct (D) Yes
F4
  • F4 These options, representing the right to purchase 46,250 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 17, 2023, which was one quarter after the date on which the option was granted.
Open filing 0001140361-26-042785 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06Flynn Sean C. Officer: Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)15,00016.25
243,750

Derived: shares × price per share. Exact value 243750.00.

16,990Direct (D) Yes
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042464 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06Flynn Sean C. Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)15,00051.92
778,800

Derived: shares × price per share. Exact value 778800.00.

1,990Direct (D) Yes
F2, F1
  • F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042464 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06Flynn Sean C. Officer: Chief Legal Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,000) — exercise price 16.25
Acquired (A)15,0000—40,000Direct (D) Yes
F3
  • F3 These options, representing the right to purchase 150,000 shares, became exercisable on November 4, 2020, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company.
Open filing 0001140361-26-042464 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06SIEGAL JONATHAN Officer: Principal Accounting Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)1,50034.90
52,350

Derived: shares × price per share. Exact value 52350.00.

2,759Direct (D) Yes
F1
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042463 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06SIEGAL JONATHAN Officer: Principal Accounting Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,50052.90
79,350

Derived: shares × price per share. Exact value 79350.00.

1,259Direct (D) Yes
F2, F1
  • F2 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 10, 2025.
  • F1 These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Open filing 0001140361-26-042463 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06SIEGAL JONATHAN Officer: Principal Accounting Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (1,500) — exercise price 34.90
Acquired (A)1,5000—1,198Direct (D) Yes
F3
  • F3 These options, representing the right to purchase 4,198 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 18, 2022, which was one quarter after the date on which the option was granted
Open filing 0001140361-26-042463 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06ZERBE ROBERT L MD Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)50013.05
6,525

Derived: shares × price per share. Exact value 6525.00.

33,495Direct (D) Yes— Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06ZERBE ROBERT L MD Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)50055.00
27,500

Derived: shares × price per share. Exact value 27500.00.

32,995Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06ZERBE ROBERT L MD Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,50013.05
32,625

Derived: shares × price per share. Exact value 32625.00.

35,495Direct (D) Yes— Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06ZERBE ROBERT L MD Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,50051.67
129,175

Derived: shares × price per share. Exact value 129175.00.

32,995Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06ZERBE ROBERT L MD Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (500) — exercise price 13.05
Acquired (A)5000—4,500Direct (D) Yes
F2
  • F2 These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-06ZERBE ROBERT L MD Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (2,500) — exercise price 13.05
Acquired (A)2,5000—2,000Direct (D) Yes
F2
  • F2 These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-11-04 Filed 2026-11-06ZERBE ROBERT L MD Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,50013.05
32,625

Derived: shares × price per share. Exact value 32625.00.

35,495Direct (D) Yes— Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-11-04 Filed 2026-11-06ZERBE ROBERT L MD Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,50045.40
113,500

Derived: shares × price per share. Exact value 113500.00.

32,995Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-11-04 Filed 2026-11-06ZERBE ROBERT L MD Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (2,500) — exercise price 13.05
Acquired (A)2,5000—5,000Direct (D) Yes
F2
  • F2 These options, representing the right to purchase a total of 17,500 shares, were originally granted on May 2, 2018, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Open filing 0001140361-26-042462 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-14MCLAUGHLIN KEVIN F Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)7,00013.05
91,350

Derived: shares × price per share. Exact value 91350.00.

25,300Direct (D) Yes— Open filing 0001140361-26-033143 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-14MCLAUGHLIN KEVIN F Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,00044.53
311,710

Derived: shares × price per share. Exact value 311710.00.

18,300Direct (D) Yes
F1
  • F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.
Open filing 0001140361-26-033143 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Soleus Capital Master Fund, L.P. Common Stock, no par value per share2.81,458,882.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-088745 Dispute this row
Soleus Capital, LLC Common Stock, no par value per share2.81,458,882.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-088745 Dispute this row
Soleus Capital Group, LLC Common Stock, no par value per share2.81,458,882.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-088745 Dispute this row
Soleus Capital Management, L.P. Common Stock, no par value per share2.81,458,882.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-088745 Dispute this row
Soleus GP, LLC Common Stock, no par value per share2.81,458,882.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-088745 Dispute this row
Guy Levy Common Stock, no par value per share2.81,458,882.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 1Open filing 0001213900-26-088745 Dispute this row
Vanguard Capital Management Common Stock5.112,603,12803/31/2026 Filed 2026-04-30SCHEDULE 13GOpen filing 0002100119-26-001241 Dispute this row
Soleus Capital Master Fund, L.P. Common Stock, no par value per share5.02,549,079.0003/31/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0001213900-26-038747 Dispute this row
Soleus Capital, LLC Common Stock, no par value per share5.02,549,079.0003/31/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0001213900-26-038747 Dispute this row
Soleus Capital Group, LLC Common Stock, no par value per share5.02,549,079.0003/31/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0001213900-26-038747 Dispute this row
Soleus Capital Management, L.P. Common Stock, no par value per share5.02,549,079.0003/31/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0001213900-26-038747 Dispute this row
Soleus GP, LLC Common Stock, no par value per share5.02,549,079.0003/31/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0001213900-26-038747 Dispute this row
Guy Levy Common Stock, no par value per share5.02,549,079.0003/31/2026 Filed 2026-04-01SCHEDULE 13GOpen filing 0001213900-26-038747 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 6Open filing 0000102909-26-002595 Dispute this row
Brown Capital Management, LLC Common Stock, No Par Value Per Share3.871,950,989.0009/30/2025 Filed 2025-11-12SCHEDULE 13G/AAmendment 10Open filing 0001398344-25-020795 Dispute this row
STATE STREET CORPORATION COMMON STOCK5.62,807,242.0009/30/2025 Filed 2025-11-10SCHEDULE 13GOpen filing 0000093751-25-000645 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,741,977 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015158,359
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to Vericel Corporation